4
Changes in Ownership
Coherus Oncology, Inc. Filed Acc 0001209191-14-067909
Director acquired 869,964 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Wahlstrom Mats · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2014-11-12 | Conversion : show line 1 in the form | +194,889 | 194,889 | I |
| 2014-11-12 | Conversion : show line 2 in the form | +26,649 | 221,538 | I |
| 2014-11-12 | Conversion : show line 3 in the form | +514,893 | 514,893 | I |
| 2014-11-12 | Conversion : show line 4 in the form | +79,950 | 594,843 | I |
| 2014-11-12 | Conversion : show line 5 in the form | +43,011 | 43,011 | I |
| 2014-11-12 | Conversion : show line 6 in the form | +10,572 | 53,583 | I |
Table II: Derivative
6 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2014-11-12 | Conversion : show line 7 in the form Series B Preferred Stock | −194,889 | 0 | I |
| 2014-11-12 | Conversion : show line 8 in the form Series B Preferred Stock | −26,649 | 0 | I |
| 2014-11-12 | Conversion : show line 9 in the form Series B Preferred Stock | −514,893 | 0 | I |
| 2014-11-12 | Conversion : show line 10 in the form Series C Preferred Stock | −79,950 | 0 | I |
| 2014-11-12 | Conversion : show line 11 in the form Series C Preferred Stock | −43,011 | 0 | I |
| 2014-11-12 | Conversion : show line 12 in the form Series C Preferred Stock | −10,572 | 0 | I |
Loading xslF345X03/doc4.xml…